Terstappen L W, de Grooth B G, Segers-Nolten I, Greve J
University of Twente, Department of Applied Physics, Enschede, The Netherlands.
Blut. 1990 Feb;60(2):81-7. doi: 10.1007/BF01720512.
The occurrence of cytotoxic lymphocyte subpopulations (i.e., CD 16+, CD 57+ and cytotoxic CD 8+) wa studied in the peripheral blood of 18 B-cell chronic lymphocytic leukemia (B-CLL) patients. The absolute numbers of CD 57+, CD 16+ and cytotoxic CD 8+ lymphocytes were increased in the peripheral blood of untreated patients as compared with healthy donors, suggesting a causal relation with the accumulation of malignant B-cells. For 5 B-CLL patients and 5 hematological normal donors, the lymphocyte subpopulations in peripheral blood, lymph nodes and bone marrow were determined. A significant immune response was observed in the lymph nodes of the patients, as reflected by the CD 3+ lymphocytes, which were 1.7-27 times larger in the patients lymph nodes than in their peripheral blood and bone marrow. In contrast, with peripheral blood this was mainly caused by an increase in CD 4+ lymphocytes. The CD 57 lymphocytes in the lymph nodes of the patients had abnormal orthogonal light-scattering signals and an abnormal density of CD 57+ receptors in comparison with their peripheral blood CD 57+ lymphocytes or the CD 57+ lymphocytes in the peripheral blood, bone marrow and tonsils of the hematological normal donors. This study shows that although a significant increase of cytotoxic lymphocytes in the peripheral blood of B-CLL patients is observed, the actual distributions of the non-malignant lymphocytes can be quite different at the actual tumor sites, i.e., bone marrow and lymph nodes.
研究了18例B细胞慢性淋巴细胞白血病(B-CLL)患者外周血中细胞毒性淋巴细胞亚群(即CD16 +、CD57 +和细胞毒性CD8 +)的发生情况。与健康供体相比,未经治疗的患者外周血中CD57 +、CD16 +和细胞毒性CD8 +淋巴细胞的绝对数量增加,提示与恶性B细胞的积累存在因果关系。对5例B-CLL患者和5例血液学正常供体,测定了外周血、淋巴结和骨髓中的淋巴细胞亚群。患者淋巴结中观察到显著的免疫反应,表现为CD3 +淋巴细胞,其在患者淋巴结中的数量比外周血和骨髓中高1.7至27倍。相比之下,在外周血中,这主要是由CD4 +淋巴细胞增加引起的。与外周血CD57 +淋巴细胞或血液学正常供体外周血、骨髓和扁桃体中的CD57 +淋巴细胞相比,患者淋巴结中的CD57淋巴细胞具有异常的正交光散射信号和异常密度的CD57 +受体。这项研究表明,虽然观察到B-CLL患者外周血中细胞毒性淋巴细胞显著增加,但在实际肿瘤部位,即骨髓和淋巴结,非恶性淋巴细胞的实际分布可能有很大差异。